We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
- Authors
Meya, David B; Manabe, Yukari C; Castelnuovo, Barbara; Cook, Bethany A; Elbireer, Ali M; Kambugu, Andrew; Kamya, Moses R; Bohjanen, Paul R; Boulware, David R
- Abstract
Cryptococcal meningitis (CM) remains a common AIDS-defining illness in Africa and Asia. Subclinical cryptococcal antigenemia is frequently unmasked with antiretroviral therapy (ART). We sought to define the cost-effectiveness of serum cryptococcal antigen (CRAG) screening to identify persons with subclinical cryptococcosis and the efficacy of preemptive fluconazole therapy.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Vol 51, Issue 4, p448
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/655143